Applied Therapeutics, Inc.APLT
| Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
---|
Research and development | 32 | 62 | 63 | 56 | 54 |
---|
General and administrative | 13 | 33 | 43 | 27 | 21 |
---|
Total costs and expenses | 46 | 94 | 106 | 83 | 75 |
---|
LOSS FROM OPERATIONS | -46 | -94 | -106 | -83 | -65 |
---|
License | - | - | - | - | 9 |
---|
Research and development services | - | - | - | - | 1 |
---|
Total Revenue | - | - | - | - | 10 |
---|
Research and development | 32 | 62 | 63 | 56 | 54 |
---|
General and administrative | 13 | 33 | 43 | 27 | 21 |
---|
Total costs and expenses | 46 | 94 | 106 | 83 | 75 |
---|
LOSS FROM OPERATIONS | -46 | -94 | -106 | -83 | -65 |
---|
Interest income | 0 | 1 | 1 | 1 | 1 |
---|
Change in fair value of warrant liabilities | - | - | - | 0 | 57 |
---|
Other expense | -0 | -0 | -1 | -0 | -0 |
---|
Total other income (expense), net | 0 | 1 | 0 | 0 | -55 |
---|
Net loss | -46 | -94 | -106 | -82 | -120 |
---|
Earnings Per Share, Basic | - | - | -4.12 | -2.18 | -1.42 |
---|
Earnings Per Share, Diluted | - | - | -4.12 | -2.18 | -1.42 |
---|
Interest income | 0 | 1 | 1 | 1 | 1 |
---|
Change in fair value of warrant liabilities | - | - | - | 0 | 57 |
---|
Other expense | -0 | -0 | -1 | -0 | -0 |
---|
Total other income (expense), net | 0 | 1 | 0 | 0 | -55 |
---|
Net loss | -46 | -94 | -106 | -82 | -120 |
---|
Net loss attributable to common stockholders-basic | -46 | -94 | -106 | -83 | - |
---|
Net loss attributable to common stockholders-diluted | -46 | -94 | -106 | -83 | - |
---|
Earnings Per Share, Basic | - | - | -4.12 | -2.18 | -1.42 |
---|
Earnings Per Share, Diluted | - | - | -4.12 | -2.18 | -1.42 |
---|